Revanesse Shape with Lido (2x1,2 ml)

Revanesse Shape acts as a rigid structural scaffold within the deep dermis or subcutaneous fat pads. The cross-linked HA matrix binds water to provide immediate mechanical "lifting" power. Unlike superficial skin boosters, this product focuses on bone-mimicking projection and long-term volume retention.

This treatment is strictly contraindicated. There is no clinical safety data regarding high-density HA injectables during fetal development. We defer all elective volumizing procedures until after childbirth.

Injection is not recommended for nursing mothers. It is advised to postpone elective aesthetic procedures until the breastfeeding period has completely concluded to ensure maximum safety.

The formulation contains 25 mg/ml of cross-linked Hyaluronic Acid of non-animal origin and 0.3% Lidocaine hydrochloride for a comfortable treatment experience.

Dosage depends on the degree of volume loss and the area of correction. Typically, 1.2 ml to 2.4 ml is used for bilateral cheek or jawline definition. Practitioners should evaluate if subtle structural support is achieved before utilizing the full density of Shape for large-scale facial remodeling.

Common side effects include localized swelling, tenderness, and potential purple bruising at the deep injection sites. To ensure a quick recovery, patients must follow our expert aftercare guide. Any persistent blanching requires immediate evaluation for vascular occlusion.

Avoid alcohol for 24h before and 48h after the procedure. Alcohol is a vasodilator that can increase post-filler swelling and worsen bruising at the deep injection sites required for high G-prime fillers.